Geode Capital Management
HCAT icon

Geode Capital Management’s Health Catalyst HCAT Stock Holding History

Geode Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.91M Sell
1,501,433
-167,046
-10% -$314K ﹤0.01% 3144
2025
Q4 		$3.99M Sell
1,668,479
-70,425
-4% -$193K ﹤0.01% 2889
2025
Q3 		$4.96M Buy
1,738,904
+76,449
+5% +$262K ﹤0.01% 2783
2025
Q2 		$6.27M Buy
1,662,455
+169,580
+11% +$667K ﹤0.01% 2614
2025
Q1 		$6.76M Buy
1,492,875
+46,275
+3% +$245K ﹤0.01% 2512
2024
Q4 		$10.2M Buy
1,446,600
+3,564
+0.2% +$28.4K ﹤0.01% 2357
2024
Q3 		$11.7M Buy
1,443,036
+66,896
+5% +$483K ﹤0.01% 2288
2024
Q2 		$8.8M Buy
1,376,140
+56,968
+4% +$366K ﹤0.01% 2401
2024
Q1 		$9.93M Buy
1,319,172
+58,504
+5% +$534K ﹤0.01% 2332
2023
Q4 		$11.7M Buy
1,260,668
+80,058
+7% +$654K ﹤0.01% 2243
2023
Q3 		$11.9M Buy
1,180,610
+50,870
+5% +$607K ﹤0.01% 2152
2023
Q2 		$14.1M Buy
1,129,740
+48,489
+4% +$577K ﹤0.01% 2083
2023
Q1 		$12.6M Buy
1,081,251
+33,302
+3% +$425K ﹤0.01% 2108
2022
Q4 		$11.1M Buy
1,047,949
+13,842
+1% +$134K ﹤0.01% 2197
2022
Q3 		$10M Sell
1,034,107
-60,955
-6% -$807K ﹤0.01% 2255
2022
Q2 		$15.9M Buy
1,095,062
+111,550
+11% +$1.9M ﹤0.01% 1932
2022
Q1 		$25.7M Buy
983,512
+65,651
+7% +$1.86M ﹤0.01% 1714
2021
Q4 		$36.4M Buy
917,861
+56,966
+7% +$2.6M ﹤0.01% 1545
2021
Q3 		$43.1M Buy
860,895
+191,007
+29% +$10.4M 0.01% 1402
2021
Q2 		$37.2M Buy
669,888
+107,574
+19% +$5.73M 0.01% 1550
2021
Q1 		$26.3M Buy
562,314
+32,879
+6% +$1.59M ﹤0.01% 1700
2020
Q4 		$23M Buy
529,435
+42,866
+9% +$1.58M ﹤0.01% 1633
2020
Q3 		$17.8M Buy
486,569
+191,648
+65% +$6.51M ﹤0.01% 1610
2020
Q2 		$8.6M Buy
294,921
+93,720
+47% +$2.59M ﹤0.01% 2012
2020
Q1 		$5.26M Buy
201,201
+99,312
+97% +$3.03M ﹤0.01% 2118
2019
Q4 		$3.54M Buy
101,889
+9,352
+10% +$310K ﹤0.01% 2658
2019
Q3 		$2.93M Buy
+92,537
New +$3.64M ﹤0.01% 2703

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management's HCAT Position: Q1 2026 in Review

Geode Capital Management reduced its Health Catalyst (HCAT) stake by 10% in Q1 2026, selling an estimated $314K and leaving 1,501,433 shares worth $1.91M. The position accounts for ﹤0.01% of the portfolio, ranked #3144.

Geode Capital Management first reported a position in HCAT in Q3 2019 and has held it in 27 quarters since. The position peaked at $43.1M in Q3 2021. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Geode Capital Management held 1,501,433 shares of Health Catalyst worth $1.91M as of Q1 2026.
  • Geode Capital Management sold 167,046 Health Catalyst shares in Q1 2026, an estimated $314K.
  • Health Catalyst made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3144 holding.
  • Geode Capital Management first reported a position in Health Catalyst in Q3 2019 and has held it in 27 quarters since.
  • Geode Capital Management's Health Catalyst position peaked at $43.1M in Q3 2021.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.